Category: Business

ITWeb TV: Open-source AI: Unlocking potential for South Africa’s SMEs

ITWeb’s Lungile Msomi talks to African Academy of Artificial Intelligence co-founders, Greg Serandos and Quinton Jacobs, about business adoption of AI, the drive for relevant skills and how South Africa can leverage the technology for competitive advantage on the continent. #itwebtv #ai #opensource While artificial intelligence (AI) holds the potential…

Continue Reading ITWeb TV: Open-source AI: Unlocking potential for South Africa’s SMEs

Translational Regenerative Medicine market is estimated to grow at a CAGR of 24.3% by 2034: Visiongain

Visiongain Reports Ltd Visiongain has published a new report entitled: Translational Regenerative Medicine Market Report 2024-2034: Forecasts by Product (Stem Cell Therapy (Autologous, Allogenic), Tissue Engineering (Scaffold, Hydrogels), Gene Therapy, Others)), by Application (Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound Healing, Ophthalmology, Others) AND Regional and Leading National Market Analysis PLUS…

Continue Reading Translational Regenerative Medicine market is estimated to grow at a CAGR of 24.3% by 2034: Visiongain

Translational Regenerative Medicine market is estimated to

Visiongain has published a new report entitled: Translational Regenerative Medicine Market Report 2024-2034: Forecasts by Product (Stem Cell Therapy (Autologous, Allogenic), Tissue Engineering (Scaffold, Hydrogels), Gene Therapy, Others)), by Application (Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound Healing, Ophthalmology, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading…

Continue Reading Translational Regenerative Medicine market is estimated to

Bristol Myers Squibb hiring Machine Learning/AI Scientist Computational Tissue Imaging Research, Translational Bioinformatics in Cambridge, MA

Working with UsChallenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work…

Continue Reading Bristol Myers Squibb hiring Machine Learning/AI Scientist Computational Tissue Imaging Research, Translational Bioinformatics in Cambridge, MA

CorGTA Inc. hiring Machine Learning Engineer (Vertex AI) in Canada

*****This company is a Data Consultancy & Solution Provider with high-profile clients that works with Data Scientists, Data Engineers, and Software Engineers to solve any & all business problems. (Data & Analytics Strategy, Data Governance, Data Warehousing, Predictive Analytics, & Cloud BI Services) Machine Learning Engineer (Vertex AI) Job Title:…

Continue Reading CorGTA Inc. hiring Machine Learning Engineer (Vertex AI) in Canada

Bioinformatics Market Is Set To Reach USD 28.6 Billion By 2030 With CAGR Of 13.73% | Marketdigits

(MENAFN– GlobeNewsWire – Nasdaq) The Global Bioinformatics Market was valued USD 10.23 Billion in 2023 and projected to reach USD 28.6 Billion by 2030, growing at a CAGR of 13.73% during the forecast period of 2023-2030 Richmond, Feb. 09, 2024 (GLOBE NEWSWIRE) — According to a research report ” Bioinformatics…

Continue Reading Bioinformatics Market Is Set To Reach USD 28.6 Billion By 2030 With CAGR Of 13.73% | Marketdigits

Shionogi Announces New Phase 3 Data Showing Early Resolution of Many Common COVID-19 Symptoms in JAMA Network Open

OSAKA, Japan–(BUSINESS WIRE)– Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced the first peer-reviewed publication of the Phase 3 portion of its pivotal, double-blind, randomized, placebo-controlled Phase 2/3 study (SCORPIO-SR) in patients with mild to moderate COVID-19 in Japan, South Korea…

Continue Reading Shionogi Announces New Phase 3 Data Showing Early Resolution of Many Common COVID-19 Symptoms in JAMA Network Open

Pacritinib Shows Transfusion Independence Benefits in Myelofibrosis

Bart Scott, MD Professor, Transplantation Program Clinical Research Division Miklos Kohary and Natalia Zimonyi Kohary Endowed Chair Fred Hutchinson Cancer Center Seattle, WA Targeted Oncology: Could you summarize the approved Janus kinase (JAK) inhibitors for patients with myelofibrosis? BART SCOTT, MD: Ruxolitinib (Jakafi) was approved in 2011, fedratinib (Inrebic) in…

Continue Reading Pacritinib Shows Transfusion Independence Benefits in Myelofibrosis

Generative AI with Google Cloud: Build with AI today

Dive into the exciting world of Generative AI (Gen AI) from Google – the revolutionary technology behind cutting-edge text, image, and code generation tools. This workshop will demystify Gen AI concepts, explore its real-world applications, and provide a foundation for harnessing its potential. Join us for a 4-hour virtual event….

Continue Reading Generative AI with Google Cloud: Build with AI today

CRISPR/Cas9 are the Most Sought Genome Editing Tools

Company Logo Global Genome Editing Market Global Genome Editing Market Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) — The “Global Genome Editing Market, 2023-2035: Focus on Technology, Industry Trends and Forecasts” report has been added to ResearchAndMarkets.com‘s offering. The global genome editing market size for technologies is estimated to be worth…

Continue Reading CRISPR/Cas9 are the Most Sought Genome Editing Tools

A Benchmark of Genetic Variant Calling Pipelines Using Metagenomic Short-Read Sequencing

Introduction Short-read metagenomic sequencing is the technique most widely used to explore the natural habitat of millions of bacteria. In comparison with 16S rRNA sequencing, shotgun metagenomic sequencing (MGS) provides sequence information of the whole genomes, which can be used to identify different genes present in an individual bacterium and…

Continue Reading A Benchmark of Genetic Variant Calling Pipelines Using Metagenomic Short-Read Sequencing

Google Cloud Platform AI Engineer – Volto Consulting

Summary: We are seeking an experienced and passionate Google Cloud Platform AI Engineer to join our team and drive innovation through the application of artificial intelligence solutions on the Google Cloud Platform (Google Cloud Platform). The ideal candidate will have a strong understanding of AI principles, cloud computing, and a…

Continue Reading Google Cloud Platform AI Engineer – Volto Consulting

Red Genes: Assessing WuXi AppTec’s Ties to the Party-Army-State

Executive Summary: WuXi AppTec, a major Chinese biotechnology and pharmaceutical firm, claimed that the company has not, does not, and will not pose a national security risk to any country in response to new legislation introduced in the US Congress. The company’s claims are undermined by WuXi Apptec’s network of…

Continue Reading Red Genes: Assessing WuXi AppTec’s Ties to the Party-Army-State

Professor of Medical Bioinformatics and Statistical Genetics job with Aarhus University (AU)

The Department of Biomedicine at Faculty of Health at Aarhus University invites applications for a position as Professor in the field of Medical Bioinformatics and Statistical Genetics as per 1 July 2024 or as soon as possible thereafter. The position is a time-limited full-time position for 5 years with extension…

Continue Reading Professor of Medical Bioinformatics and Statistical Genetics job with Aarhus University (AU)

Bioinformatics Market is Set to Reach USD 28.6 Billion by

Richmond, Feb. 09, 2024 (GLOBE NEWSWIRE) — According to a research report “Bioinformatics Market”, by tools Type (BLAST, BioPerl, InterMine, Others), Services (Genome Sequencing, RNA sequencing, Metagenomic Analysis, Epigenomic, Others), Application (Drug discovery, Personalized medicine, Preventive medicine, Transcriptions, Metabolomics, Gene therapy, Others) Sectors (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental…

Continue Reading Bioinformatics Market is Set to Reach USD 28.6 Billion by

Remote Software Quality Engineer III – Bioinformatics Job at Natera

JOB TITLE: Software Quality Engineer III – Bioinformatics LOCATION: Remote, USA PRIMARY RESPONSIBILITIES: Perform software verification, define and execute test cases and scenarios required for software quality assurance and regulatory compliance. Perform system analysis, assess risk, and develop strong test strategies by analyzing product design and technical specifications, and by…

Continue Reading Remote Software Quality Engineer III – Bioinformatics Job at Natera

Danaher Jobs – Principal Bioinformatics Scientist

At Cepheid, we are passionate about improving health care through fast, accurate diagnostic testing. Our mission drives us, every moment of every day, as we develop scalable, groundbreaking solutions to solve the world’s most complex health challenges. Our associates are involved in every stage of molecular diagnostics, from ideation to…

Continue Reading Danaher Jobs – Principal Bioinformatics Scientist

Shedding Light on BIA-ALCL Risks

In a society that celebrates individuality and self-expression, the journey to aesthetics takes many forms. One such road, taken by countless women seeking empowerment and confidence, is breast augmentation. This blog dives deep into the dark and flip side of breast augmentation- Allergan breast implant lawsuits. Before answering the query…

Continue Reading Shedding Light on BIA-ALCL Risks

Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementation

dc.contributor.author Lim, Ryan G dc.contributor.author Al-Dalahmah, Osama dc.contributor.author Wu, Jie dc.contributor.author Gold, Maxwell P dc.contributor.author Reidling, Jack C dc.contributor.author Tang, Guomei dc.contributor.author Adam, Miriam dc.contributor.author Dansu, David K dc.contributor.author Park, Hye-Jin dc.contributor.author Casaccia, Patrizia dc.contributor.author Miramontes, Ricardo dc.contributor.author Reyes-Ortiz, Andrea M dc.contributor.author Lau, Alice dc.contributor.author Hickman, Richard A dc.contributor.author Khan,…

Continue Reading Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementation

Treating the Untreatable with Precision Therapies – A $4 trillion Opportunity?

Precision Therapies For Targeted Results Precision therapies have always been the ultimate goal of medicine. Instead of drugs acting on multiple parts of the body, these therapies would only target one organ, one cell, or even one gene. In theory, not only would this be a lot more efficient, but…

Continue Reading Treating the Untreatable with Precision Therapies – A $4 trillion Opportunity?

Molecular Dynamics Software Market to Witness Revolutionary

Molecular Dynamics Software Market Global “Molecular Dynamics Software Market” Research report is an in-depth study of the market Analysis. Along with the most recent patterns and figures that uncovers a wide examination of the market offer. This report provides exhaustive coverage on geographical segmentation, latest demand scope, growth rate analysis…

Continue Reading Molecular Dynamics Software Market to Witness Revolutionary

Did COVID vaccines kill 14X more people than they saved?

Did a study just show that COVID-19 vaccines killed 14x more people than they saved?! Take a look at the viral claim, and find out what the facts really are!   Claim : COVID Vaccines Kill 14X More People Than They Saved! People are sharing an article (archive) by The…

Continue Reading Did COVID vaccines kill 14X more people than they saved?

what is in the pipeline?

According to the World Health Organization (WHO), around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. Although treatments are already available for the disease – which include narrow-spectrum anti-epileptic drugs (AEDs) to treat specific types of seizures, and broad-spectrum AEDs to treat…

Continue Reading what is in the pipeline?

CSRD compliance in biotech: is the industry ready?

The EU’s Corporate Sustainability Reporting Directive (CSRD), effective from the beginning of 2023, brings significant implications and challenges for the biotech industry. This directive aims to embed Environmental, Social, and Governance (ESG) elements as fundamental components of annual corporate reporting, necessitating a range of requirements and adjustments for companies in…

Continue Reading CSRD compliance in biotech: is the industry ready?

Can gene therapy be the key to restoring hearing loss?

Gene therapy has had a number of success stories with regards to treating blood disorders like hemophilia and beta-thalassemia, as well as in cancer research. Now, the latest breakthrough in gene therapy has been in restoring hearing loss in an 11-year-old boy.  A team of scientists at the Children’s Hospital…

Continue Reading Can gene therapy be the key to restoring hearing loss?

Investors Sue BioVie (BIVI) After Potential Scientific

SAN FRANCISCO, Feb. 09, 2024 (GLOBE NEWSWIRE) — Hagens Berman urges BioVie Inc. (NASDAQ: BIVI) investors who suffered substantial losses to submit your losses now. Class Period: Aug. 5, 2021 – Nov. 29, 2023Lead Plaintiff Deadline: Mar. 19, 2024Visit: www.hbsslaw.com/investor-fraud/BIVI Contact An Attorney Now: BIVI@hbsslaw.com          …

Continue Reading Investors Sue BioVie (BIVI) After Potential Scientific

This new approach could revolutionize knee osteoarthritis treatment

BioSenic, a clinical-stage Belgian-headquartered company specializing in serious autoimmune and inflammatory diseases and cell therapy, will be sharing data on its late-clinical asset JTA-004 for the treatment of knee osteoarthritis at the Osteoarthritis Research Society International (OARSI) World Congress 2024. The event takes place in Vienna, Austria, from April 18…

Continue Reading This new approach could revolutionize knee osteoarthritis treatment

5 hot biotechnology careers skyrocketing in demand

With many exciting discoveries to make and new problems to solve, the biotechnology industry provides many career opportunities that could make a difference in people’s lives. So, if you are searching for a career in the field, we have listed five biotechnology careers that are currently in high demand, and…

Continue Reading 5 hot biotechnology careers skyrocketing in demand

what will therapy look like in 2034?

Drugs like PARP inhibitors and chimeric antigen receptor (CAR) therapies, and advancements in artificial intelligence in drug discovery, have spurred hope for improved cancer care in the past year. Rigorous research has paved the way for a declining cancer death rate – by 33% to be precise – since the…

Continue Reading what will therapy look like in 2034?

16 UK biotech companies you should know about

The UK is home to several biotech hubs, including the famous ‘golden triangle’, made up of Oxford, Cambridge, and London. In fact, after a $700 million surge in funding in the third quarter of 2023, the UK biotech scene is now one of the most vibrant in Europe, laying the…

Continue Reading 16 UK biotech companies you should know about

The biggest private biotech investments in January 2024

The companies Jixing Pharmaceuticals, COUR Pharmaceuticals, and OnCusp Therapeutics bagged the biggest private biotech investments in January 2024. Around the world, immunology, oncology, and drug discovery players attracted the biggest funding rounds overall.  The first month of 2024 saw a lot of initial public offering (IPO) success stories, suggesting a…

Continue Reading The biggest private biotech investments in January 2024

Top antibody-drug conjugate (ADC) companies leading the industry

The antibody-drug conjugate (ADC) field is witnessing an expansion in the variety of conjugation techniques, linker chemistry, and payloads being used, moving beyond traditional tubulin inhibitors to include novel mechanisms of action. Investments in ADC research continue to grow, with significant funding rounds and acquisitions. For example, Novo Holdings’ $105…

Continue Reading Top antibody-drug conjugate (ADC) companies leading the industry

Recombinant Human Serpin E1, Transfected HEK293 Overexpression Cell Culture Supernatant

Recombinant Human Serpin E1, Transfected HEK293 Overexpression Cell Culture Supernatant | RayBiotech The store will not work correctly in the case when cookies are disabled. JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on…

Continue Reading Recombinant Human Serpin E1, Transfected HEK293 Overexpression Cell Culture Supernatant

The promising horizon of hair loss treatments

There hasn’t been a lot of hair loss treatment progress in the last twenty years. However several biotech companies are hot on the case and are getting tantalizingly close to the breakthrough that many patients hope for. With body dysmorphia magnified by the omnipresent digital world, psychiatrists have increasingly linked…

Continue Reading The promising horizon of hair loss treatments

Unveiling tomorrow’s cures: insights from Cardinal Health

This week on the podcast, we have a conversation with Fran Gregory, vice president of Emerging Therapies at Cardinal Health.  The discussion covers the company’s role in healthcare, biosimilars, the latest in cell and gene therapies, and Advanced Therapies Week. About Cardinal Health Cardinal Health is a distributor of pharmaceuticals…

Continue Reading Unveiling tomorrow’s cures: insights from Cardinal Health

Biotech job market 2024: what to expect?

The past year saw a string of pipeline cuts and downsizing plans strike the biotech job market. Have layoffs spooked young professionals looking for a way into the industry, and does the employment landscape seem to be looking up this year? Employment in the life sciences industry had hit a…

Continue Reading Biotech job market 2024: what to expect?

Buy Slurm Bottle Cap style pin #Futurama #MadeInUSA Online at desertcart Antigua and Barbuda

Disclaimer: The price shown above includes all applicable taxes and fees. The information provided above is for reference purposes only. Products may go out of stock and delivery estimates may change at any time. desertcart does not validate any claims made in the product descriptions above. For additional information, please…

Continue Reading Buy Slurm Bottle Cap style pin #Futurama #MadeInUSA Online at desertcart Antigua and Barbuda

Pomerantz Law Firm Announces the Filing of a Class Action

NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR). The class action, filed in the United States District Court for the District of Massachusetts, and docketed under 24-cv-10152, is on behalf of…

Continue Reading Pomerantz Law Firm Announces the Filing of a Class Action

Samsung and Google Cloud Gen AI: A New Era of Smartphone

Samsung and Google Cloud recently announced a new multi-year partnership to bring Google Cloud’s generative artificial intelligence (Gen AI) technology to Samsung smartphone users around the globe. Since the announcement, the collaboration has been hailed as highlighting a revolutionary change in the global smartphone market. Technology companies are increasingly using…

Continue Reading Samsung and Google Cloud Gen AI: A New Era of Smartphone

BioVie Sued By Block & Leviton LLP for Securities Law Violations

BOSTON, Jan. 19, 2024 (GLOBE NEWSWIRE) — Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that it has filed a class action lawsuit on behalf of shareholders against BioVie, Inc. (NASDAQ: BIVI) and certain of its executives, for securities fraud. The complaint was brought in United States…

Continue Reading BioVie Sued By Block & Leviton LLP for Securities Law Violations

Samsung joins forces with Google Cloud to launch Generative AI feature

Samsung joins forces with Google Cloud to launch the Generative AI feature to enhance usability on the newest mobile phone. The Samsung Galaxy S24 Series is preparing to enable 2 new features such as Gemini Pro and Imagen 2 from Google that will help create New messages, sounds and photos…

Continue Reading Samsung joins forces with Google Cloud to launch Generative AI feature

Nanomaterials | Free Full-Text | Tissue Nanotransfection Silicon Chip and Related Electroporation-Based Technologies for In Vivo Tissue Reprogramming

As mentioned above, compared to conventional electrodes, the microneedle-type electrodes exhibit better pain management and lower voltage requirements due to the microscale needle dimensions. To manufacture microneedle-type electrode devices with precise patterning and high yields, sophisticated manufacturing techniques are often utilized. Some of these techniques include laser-cutting, metallization, and semiconductor…

Continue Reading Nanomaterials | Free Full-Text | Tissue Nanotransfection Silicon Chip and Related Electroporation-Based Technologies for In Vivo Tissue Reprogramming

ADC Therapeutics (ADCT) Rises 43% in a Month: Here’s Why

ADC Therapeutics ADCT is a commercial-stage biotech company focused on developing novel antibody-drug conjugates (ADC) to treat patients with hematologic malignancies and solid tumors. Currently, ADC Therapeutics has only one marketed drug in its portfolio, Zynlonta, which the FDA approves to treat relapsed or refractory (r/r) diffuse large B-cell lymphoma…

Continue Reading ADC Therapeutics (ADCT) Rises 43% in a Month: Here’s Why

Study Highlights Treatment Patterns, Costs for DLBCL Not Treated With Stem Cell Transplant

New research highlights treatment patterns, health care resource utilization (HCRU), and costs associated with patients who have diffuse large B-cell lymphoma (DLBCL) who did not undergo stem cell transplantation in the second-line setting between 2009 and 2020. Of a 750-patient cohort, 86.8% received rituximab plus cyclophosphamide, doxorubicin, vincristine (Oncovin), and…

Continue Reading Study Highlights Treatment Patterns, Costs for DLBCL Not Treated With Stem Cell Transplant

Did China really lie about Covid-19? Here’s what US says

A health worker injects a man with a shot of the Inavac vaccine for Covid-19 at the Jakarta provincial health office on Dec. 19, 2023. — AFP China most certainly acquired the first known gene sequence for Covid-19 weeks before making it public, despite Beijing’s assertion that it did so…

Continue Reading Did China really lie about Covid-19? Here’s what US says

First patients treated with Abbott’s pulsed field ablation offering

Abbott announced this week that more than 30 patients in Australia were treated with the company’s new pulsed field ablation (PFA) system, representing the first time the technology has been used to treat arrhythmias such as atrial fibrillation in a clinical setting. The procedures were performed by Prash Sanders, MBBS,…

Continue Reading First patients treated with Abbott’s pulsed field ablation offering

Carter’s coming to Santa Rosa Plaza later this spring

Santa Rosa Plaza will have a baby and young children’s clothing store once again with the upcoming opening of Carter’s later this spring. The mall hasn’t had a dedicated store for baby and young children’s clothing since The Children’s Place closed a few years ago. Jackie Gonzalez, director of marketing…

Continue Reading Carter’s coming to Santa Rosa Plaza later this spring

Electroporation Instruments Market Insights, Market Players and Forecast Till 2031

In 2024, “Electroporation Instruments Market Size “, Status and Market Insights, forecast to 2031 “Electroporation Instruments Market” by Types (Total Electroporation System, Eukaryotic Electroporation System, Microbial Electroporation System), End User (Biotechnology and Pharmaceutical Company, Hospital Laboratories, Academic Research Institutions, Others), Global Electroporation Instruments Market Due to the COVID-19 pandemic, the…

Continue Reading Electroporation Instruments Market Insights, Market Players and Forecast Till 2031

Postdoc/assistant professor in molecular biology and bioinformatics: Structural variations associated to circular DNA in cancer – University of Copenhagen – job portal

Job Portal Postdoc/assistant professor in molecular biology and bioinformatics: Structural variations associated to circular DNA in cancer Department of Biology, Faculty of Science at University of Copenhagen is offering a position in molecular biology and bioinformatics for a Postdoc/assistant professor for the analysis of extrachromosomal circular DNA in 1 April…

Continue Reading Postdoc/assistant professor in molecular biology and bioinformatics: Structural variations associated to circular DNA in cancer – University of Copenhagen – job portal

Review Board Approves Phase 2/3 Trial of IHL-42X in Obstructive Sleep Apnea

According to a recent announcement, an independent Institutional Review Board (IRB) has approved the protocol for Incannex’s phase 2/3 RePOSA trial (NCT06146101) assessing its investigational agent IHL-42X in patients with obstructive sleep apnea (OSA). Start-up for the trial is currently in progress with 24 sites selected in the US, 13…

Continue Reading Review Board Approves Phase 2/3 Trial of IHL-42X in Obstructive Sleep Apnea

FDA Approves Balversa for Locally Advanced, Metastatic Urothelial Carcinoma

Image credit: Matthieu | stock.adobe.com The FDA has approved Balversa (erdafitinib) for adults with locally advanced or metastatic urothelial carcinoma with susceptible FGFR3 genetic mutations whose disease progressed on or following one line of systemic therapy.1 The regulatory action amends the accelerated approval granted by the FDA in April 2019 for patients…

Continue Reading FDA Approves Balversa for Locally Advanced, Metastatic Urothelial Carcinoma

Genomic insights into Plasmodium vivax population structure and diversity in central Africa | Malaria Journal

Hamblin MT, Di Rienzo A. Detection of the signature of natural selection in humans: evidence from the Duffy blood group locus. Am J Hum Genet. 2000;66:1669–79. Article  CAS  PubMed  PubMed Central  Google Scholar  Hamblin MT, Thompson EE, Di Rienzo A. Complex signatures of natural selection at the Duffy blood group…

Continue Reading Genomic insights into Plasmodium vivax population structure and diversity in central Africa | Malaria Journal

pPLK GFP Puro Luc shRNA Plasmid

Catalog number PVTB80045-3a Price 356 EUR Size 2 ug Kit Plasmid mini made and maxi DNA purification kits can be silica gel or anion exchange, endotoxin free and are used to produce pure plasmids that are small DNA molecules within a cell separated from chromosomal DNA and can replicate independently. They are most…

Continue Reading pPLK GFP Puro Luc shRNA Plasmid

Detection of DNA methylation signatures through the lens of genomic imprinting

Animals and samples The study included 10 pigs, 8 pigs were bred at the INRAE experimental farm (doi.org/doi.org/10.15454/1.5572415481185847E12) and 2 pigs come from breeding organizations in accordance with the French and European legislation on animal welfare. The animals belong to the same family, except for one LW animal. Animals were…

Continue Reading Detection of DNA methylation signatures through the lens of genomic imprinting

FDA grants full approval to erdafitinib for FGFR3-positive urothelial carcinoma

The FDA has granted a full approval to erdafitinib (Balversa) for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma with susceptible FGFR3 genetic alterations whose disease has progressed on or after at least 1 line of prior systemic therapy. It is not recommended for patients who,…

Continue Reading FDA grants full approval to erdafitinib for FGFR3-positive urothelial carcinoma

Federal secrets spill on COVID origins amid rodent research on risks of lab mods, vax in pregnancy

The National Institutes of Health appears to be struggling to hide its dirty laundry on COVID-19 origins against a rash of leaks, congressional probes, and Freedom of Information Act requests, even when officials are determined to thwart sunlight. The ongoing exposure of their communications and actions isn’t the only thing…

Continue Reading Federal secrets spill on COVID origins amid rodent research on risks of lab mods, vax in pregnancy

How to use ChatGPT for data analysis and research

Do you have large PDFs, Excel spreadsheets, CSV files or mountains of data you need to analyze quickly and effectively. Using AI can quickly provide results you can use to track trends, opportunities and issues that may be happening in your business market or sector. Today in the fast-paced world…

Continue Reading How to use ChatGPT for data analysis and research

The biggest private biotech investments in December 2023

The companies Tome Biosciences, Bicara Therapeutics, and Seismic Therapeutic bagged the biggest biotech investments in December 2023. Around the world, food, immunology, oncology, central nervous system (CNS), and biofermentation players attracted the biggest funding rounds overall.  Although December is generally a quiet time for biotech fundraising, there were still some…

Continue Reading The biggest private biotech investments in December 2023

Ten NK cell therapy companies to look out for this year

Natural killer (NK) cells are white blood cells that are a part of the body’s defense mechanism. These cells are on the lookout for any kind of disruption in the immune system, and can kill diseased cells like tumor cells. NK cells are being used in clinical applications to treat…

Continue Reading Ten NK cell therapy companies to look out for this year

Could natural killer cells revolutionize Alzheimer’s treatment?

This week on the podcast, we have a conversation with Dr Paul Song, CEO of NKGen Biotech, a company with its sights set on changing the Alzheimer’s disease treatment landscape with natural killer cells. The company’s natural killer (NK) cell Alzheimer’s treatment uses a patient’s cells, collected by a simple…

Continue Reading Could natural killer cells revolutionize Alzheimer’s treatment?

when brain organoids meet AI for disruptive progress

It was in the early 2010s when researchers laid the foundation for brain organoids developed from stem cells. Now, more than a decade later, they have been used to power Brainoware, a biohybrid computer that can perform speech recognition tasks. This computer is like no other, as it combines a…

Continue Reading when brain organoids meet AI for disruptive progress

The future of diabetes treatment: Is a cure possible?

Diabetes has become an epidemic, sentencing over 537 million people worldwide to lifelong medication. Science is striving to find a diabetes treatment that can cure this chronic disease, but how close are we? Diabetes is the major cause of blindness, kidney failure, heart attack, and stroke. It is estimated that…

Continue Reading The future of diabetes treatment: Is a cure possible?

Biologics tech transfer: key success factors

Tech transfers play a vital role in ensuring that medicines reach patients on time. We explore the different stages of tech transfer, and the critical factors that can help biotechs optimize their biologics transfer projects. The healthcare industry aims to efficiently deliver innovative therapies to those in need. Tech transfer,…

Continue Reading Biologics tech transfer: key success factors

Five biotech companies taking Florida by storm

Florida is currently home to the nation’s second-largest medical device manufacturing industry, second-largest pharmaceuticals manufacturing industry, and the fourth-largest biotech R&D industry, making it a large life sciences hub within the U.S. So, in this article, with more than 2,300 establishments operating within the Florida life sciences industry as a…

Continue Reading Five biotech companies taking Florida by storm

What is new in bladder cancer treatment? The latest breakthroughs

According to the World Health Organisation, 573,278 new cases of bladder cancer were diagnosed in 2020, making it the 10th most common type of cancer. Bladder cancer most commonly starts in the urothelial cells lining the inside of the bladder but can also develop in other areas like the kidneys…

Continue Reading What is new in bladder cancer treatment? The latest breakthroughs

Highlights of the 2024 JPM Healthcare Conference

Like every year, 2024 kicked off with a bang for the biotech industry, as thousands gathered at the J.P. Morgan Health Conference (JPM) that took place in San Francisco, last week. One of the largest healthcare conventions in the world, JPM recaps the glories as well as the gloom of…

Continue Reading Highlights of the 2024 JPM Healthcare Conference

GLP-1 agonists: what’s the hype about?

Glucagon-like peptide 1 (GLP-1) agonists were on everybody’s mind at the recent JPM healthcare conference in the U.S. as it was one of the major highlights at the event. But all the hype around this class of drugs, which took off when Ozempic was given the go-ahead by the U.S….

Continue Reading GLP-1 agonists: what’s the hype about?

could it be a cure?

When CASGEVY, the first CRISPR-based therapy, was approved by the FDA in December, it gave CRISPR technology the validation it needed. Any promise it had held before that moment was simply investigational. In this case, the approval of CASGEVY was granted for the treatment of two blood disorders – sickle…

Continue Reading could it be a cure?

Google Gemini: Everything you need to know about the latest generative AI platform. Technostation

With the launch of its new generative AI platform, Gemini, earlier this month, Google is attempting to create a stir. However, while Gemini seems promising in many areas, it is lacking in others. What, then, is a Gemini? What applications does it have? And how does it compare with the…

Continue Reading Google Gemini: Everything you need to know about the latest generative AI platform. Technostation

Isomorphic signs drug discovery deals with Eli Lilly and Novartis

The company aims to use the power of AI to tackle various diseases and could receive nearly $3bn from its new research collaborations. DeepMind spin-out Isomorphic Labs has signed two deals with pharma giants to discover new drugs, which could lead to billions in profit for the company. The Alphabet…

Continue Reading Isomorphic signs drug discovery deals with Eli Lilly and Novartis

Inotrem Successfully Reaches Agreement with the FDA for a Phase 3 Registration Trial for Nangibotide in Septic Shock

Novel biomarker-guided Phase 3 registration trial in septic shock with an enrichment strategy-based patient selection. Historic paradigm shift in Primary endpoint: from all causes of mortality at Day 29 to proportion of patients alive and free of organ support at Day 29. PARIS, January 08, 2024–(BUSINESS WIRE)–Inotrem, an advanced clinical…

Continue Reading Inotrem Successfully Reaches Agreement with the FDA for a Phase 3 Registration Trial for Nangibotide in Septic Shock

Restriction Enzyme Market is set to Reach US$ 647.41 million at a CAGR of 5.7% from the forecast period 2023 to 2031

Growth Plus Reports Pune, Jan. 08, 2024 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global Restriction Enzyme Market is expected to clock US$ 647.41 million by 2031 and to grow at a CAGR of 5.7% during the forecast period. The Restriction Enzyme Market…

Continue Reading Restriction Enzyme Market is set to Reach US$ 647.41 million at a CAGR of 5.7% from the forecast period 2023 to 2031

Novartis pays Isomorphic Labs $37.5 million in collab deal

Isomorphic Labs is a digital biology company that says its mission is to redefine drug discovery using artificial intelligence (AI) and says the collaboration with Novartis is to discover small molecule therapeutics against three undisclosed targets.   “Isomorphic Labs and Novartis hold a shared purpose to reimagine medicine to improve and…

Continue Reading Novartis pays Isomorphic Labs $37.5 million in collab deal

Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma

Vincerx Pharma, Inc. Investigators from the National Institutes of Health (NIH) report 2 partial responses (PR) in 3 peripheral T-cell lymphoma (PTCL) patients and 1 PR in 2 double-hit diffuse large b-cell lymphoma (DH-DLBCL) patients in ongoing dose-escalation trial of enitociclib in combination with venetoclax and prednisone Vincerx remains on…

Continue Reading Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma

Unleash the Power of Vector Search with Vertex AI

Unleash the Power of Vector Search with Vertex AI Introduction What is Vector Search? The Importance of Vector Search for Businesses Getting Started with Building Production Quality Vector Search Services with Google Cloud Vertex AI Benefits of Vector Search Technology Vector Search versus Traditional Databases How AI Organizes Data Using…

Continue Reading Unleash the Power of Vector Search with Vertex AI

10 Kaggle Competitions Every Young Data Scientist Should Check Out

Unlike high school lessons and exams, competitions can offer some much-needed practical experience. Participating in data science competitions not only allows you to hone your coding and analytical skills but also provides hands-on experience in tackling real-world problems. These competitions act as a dynamic playground where you can put your…

Continue Reading 10 Kaggle Competitions Every Young Data Scientist Should Check Out

Google’s AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery – Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Eli Lilly (NYSE:LLY), Novartis (NYSE:NVS)

Isomorphic Labs, a London-based spin-out of Alphabet Inc GOOG GOOGL Google’s AI R&D division DeepMind, has announced strategic partnerships with Eli Lilly And Co LLY and Novartis AG NVS.  These alliances aim to leverage AI to discover new medications to treat diseases.  The combined value of these deals is around $3 billion.  Isomorphic will receive $45 million upfront from Eli Lilly, potentially…

Continue Reading Google’s AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery – Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Eli Lilly (NYSE:LLY), Novartis (NYSE:NVS)

2 low-priced gene therapy stocks to speculate on

Key Points bluebird bio has three FDA-approved gene therapy treatments that are planning to commercialize after its $150 million secondary offering of common shares priced at $1.50 per share. bluebird bio’s latest FDA approval, LYFGENIA, is a one-time treatment for sickle cell disease, which is priced around $3.1 million per…

Continue Reading 2 low-priced gene therapy stocks to speculate on

Bayer’s Menopause Drug Elinzanetant Met Primary Endpoints in Phase 3 Studies

By Pierre Bertrand Bayer said that its menopause drug Elinzanetant met the primary endpoints of its Oasis 1 and 2 Phase 3 studies. When compared with placebo, the drug showed a statistically significant reduction in the frequency and the severity of moderate to severe vasomotor symptoms, also known as hot…

Continue Reading Bayer’s Menopause Drug Elinzanetant Met Primary Endpoints in Phase 3 Studies

Proinflammatory chemokine CXCL14 activates MAS-related G protein-coupled receptor MRGPRX2 and its putative mouse ortholog MRGPRB2

Reagents and peptides CXC motif chemokine 14 (CXCL14) was purchased from BIOZOL (Eching, Germany). Proadrenomedullin N-terminal 20 peptide (PAMP-20) was obtained from Tocris Bioscience (Bristol, UK), and cortistatin-14 was from GenScript (NJ, USA). Custom synthesis of CXCL14 analogs was performed by JPT Peptide Technologies (Berlin, Germany) (see Supplementary Fig. 6). Stock…

Continue Reading Proinflammatory chemokine CXCL14 activates MAS-related G protein-coupled receptor MRGPRX2 and its putative mouse ortholog MRGPRB2

Domestic pigs are susceptible to experimental infection with non-human primate-derived Reston virus without the need for adaptation

Ethics and animal welfare statement All infectious work with RESTV, including sample inactivation, was performed in the Containment Level 4 laboratory (CL4) in accordance with the policies and protocols outlined by the Canadian Science Centre for Human and Animal Health Institutional Biosafety Committee. All animal work was performed in strict…

Continue Reading Domestic pigs are susceptible to experimental infection with non-human primate-derived Reston virus without the need for adaptation

Restriction Enzyme Market is set to Reach US$ 647.41

Pune, Jan. 08, 2024 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global Restriction Enzyme Market is expected to clock US$ 647.41 million by 2031 and to grow at a CAGR of 5.7% during the forecast period. The Restriction Enzyme Market is witnessing significant…

Continue Reading Restriction Enzyme Market is set to Reach US$ 647.41

Amid second-largest wave of COVID infections in the US, Florida’s surgeon general calls to halt mRNA vaccines

On Friday, wastewater data from Biobot Analytics and the US Centers for Disease Control and Prevention (CDC) affirmed that the US has now reached its second-highest level of COVID-19 infections of the pandemic. It is anticipated that by midweek, rates of infections will reach 2 million per day with approximately…

Continue Reading Amid second-largest wave of COVID infections in the US, Florida’s surgeon general calls to halt mRNA vaccines

CRISPR Therapeutics Highlights Strategic Priorities and

ZUG, Switzerland and BOSTON, Jan. 08, 2024 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and 2024 outlook as the Company enters its next phase of growth. “We had a landmark year in 2023, marked…

Continue Reading CRISPR Therapeutics Highlights Strategic Priorities and

The best countries for biotech according to the OECD

The OECD recently published an update on key biotechnology indicators, an opportunity for us to delve into the top-performing countries in the field. With the highest number of active biotech companies (2,840) and an R&D intensity added value of 17%, the U.S. remains a strong leader in the industry. But…

Continue Reading The best countries for biotech according to the OECD

Can GLP-1 agonists treat cardiovascular diseases?

Glucagon-like peptide 1 (GLP-1) agonists have proven their therapeutic mettle in treating metabolic diseases like diabetes and obesity, and now, researchers are studying their effects on cardiovascular disease.  These drugs mimic glucagon-like peptide 1, a hormone that stimulates insulin production in the body. So, when blood sugar levels are elevated…

Continue Reading Can GLP-1 agonists treat cardiovascular diseases?

Revolutionizing acne treatment with CRISPR technology

Eligo Bioscience is a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, and in its crosshairs, initially, is moderate to severe acne vulgaris, an inflammatory disease that affects about 3% of the global population. This week, we talk to Xavier Duportet, CEO…

Continue Reading Revolutionizing acne treatment with CRISPR technology

Five AI drug discovery companies you should know about

Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the industry now embracing the technology, we take a look at five of the top AI drug discovery companies.  The…

Continue Reading Five AI drug discovery companies you should know about

Incredible Inventions: Innovations That Changed The World

By Sophia Maddox | January 1, 2024 Discover the World Using GPS Welcome to a world where imagination knows no bounds and human ingenuity has the power to reshape the course of history. It’s a world where creativity and innovation are the driving forces, pushing the boundaries of what was…

Continue Reading Incredible Inventions: Innovations That Changed The World

The Essential 10 Skills to Secure Your Dream Data Science Job | by The Tech Guy | Jan, 2024

In the rapidly evolving landscape of data science, proficiency extends beyond just technical know-how. To truly excel in this field, aspiring data scientists must cultivate a diverse skill set that encompasses both technical expertise and softer, more nuanced abilities. Here are the top 10 skills to prioritize: 1. Programming Proficiency…

Continue Reading The Essential 10 Skills to Secure Your Dream Data Science Job | by The Tech Guy | Jan, 2024

Improve Open Data Cloud with New Generative AI Solutions from SAP and Google Cloud for Businesses | by IPSpecialist | Jan, 2024

At Google Cloud Next, SAP and Google Cloud announced an expanded relationship to support organizations in making the most of data and generative AI. The companies will use SAP Datasphere and Vertex AI to connect their open data clouds to offer new generative AI-driven industrial solutions, initially focusing on the…

Continue Reading Improve Open Data Cloud with New Generative AI Solutions from SAP and Google Cloud for Businesses | by IPSpecialist | Jan, 2024

cfDNA Extraction Sensitivity Controls – cfDNA Extraction Sensitivity Controls

Does your cfDNA extraction process affect the Limit of Detection (LOD) of a particular gene target? Our new products, cfDNA Extraction Sensitivity Panels and Extraction Low Positive Controls, can help your research and development for liquid biopsy assays. NEW PRODUCTS: cfDNA EXTRACTION SENSITIVITY PANELS &  CONTROLS The Extraction Sensitivity Controls…

Continue Reading cfDNA Extraction Sensitivity Controls – cfDNA Extraction Sensitivity Controls

Ophelia AI, Pytorch Transition, and Overtrust in XAI

Revolutionary AI Advances: Ophelia AI, Pytorch Transition, and Overtrust in XAI Table of Contents: Introduction Ophelia: An Artificial Intelligence Chatbot 2.1 Purpose of Ophelia 2.2 Ophelia’s Conversational Abilities The Importance of Artificial Intelligence Explainability AI Applications in Different Industries 4.1 Greeting Guests at Hotels 4.2 Acting as a Host at…

Continue Reading Ophelia AI, Pytorch Transition, and Overtrust in XAI

10 Free Short Courses To Master Generative AI | by GGR | Jan, 2024

This article introduces you to 10 accessible, yet comprehensive, short courses that can help you master generative AI. Whether you are a novice aspiring to learn the basics or a professional looking to refine your skills, these courses promise a wealth of knowledge without a price tag. As we walk…

Continue Reading 10 Free Short Courses To Master Generative AI | by GGR | Jan, 2024

80 parttime, contract internship, remotely Banking, Bioinformatics, Digital, e-commerce, Finance, Information Technology, Investment, Research industry

Job Category Any CategoryJobInternshipWork from Home Job Type Any Job TypesFull-timePart-timeContractVolunteer Location Any CountryUKCanadaAustraliaPakistanIrelandGermanyUSASwedenNew ZealandMalaysiaRussiaNetherlandDubaiSwitzerlandJapanVietnamItalyDenmarkOnlineGeorgiaLatviaSingaporeChinaNetherlandsIndiaFranceBelgiumBrazilColombiaEuropeEstoniaThailandNorwayNigeriaQatarCambodiaUAESouth KoreaAustriaTurkeyworldwideADB CountriesIndonesiaSaudi Arabia Industry Any Industry athletic apparel and footwear Refugee AgencyAccredited registrarAeronauticsAerospaceAirlineappliance manufacturerArtificial Intelligencearts, entertainment, and recreation sectorAstronomical ResearchAutomationAutomativeAviationBankingBioinformaticsBroadcastingBusiness Administrationcar manufacturingchemicalCivic and Social OrganizationsCivil EngineeringConsumer goodsCreativity and Innovation DevelopmentCyber SecurityDairyingData analyticsDevelopmentDigitale-commerceEducationEducationElectric Power GenerationEnergyEngineeringEngineering Professional…

Continue Reading 80 parttime, contract internship, remotely Banking, Bioinformatics, Digital, e-commerce, Finance, Information Technology, Investment, Research industry

Test could identify more cancer patients eligible for immunotherapy

Revising current testing guidelines so that a more sophisticated test could be used more often would enable 6,000 more people in the United States to receive immunotherapy, researchers say. Photo by Adobe Stock/HealthDay News More patients could benefit from immunotherapy, a highly effective treatment for some cancers, new research suggests….

Continue Reading Test could identify more cancer patients eligible for immunotherapy

Resurrection Biology’ Gains Momentum As Scientists Explore Bringing Life Back from the Past

The field of “resurrection biology” is gaining prominence across the globe, as scientists embark on endeavors to revive elements of the past. This scientific pursuit, although far from the fictional genetically engineered dinosaurs of “Jurassic Park,” encompasses a range of research objectives. What Resurrection Biology Entails Credit: DepositPhotos Science studies…

Continue Reading Resurrection Biology’ Gains Momentum As Scientists Explore Bringing Life Back from the Past

Google’s VideoPoet: Revolutionizing AI Video Generation

Google’s VideoPoet: A Leap Forward in AI Video Generation Google’s latest innovation, the VideoPoet, represents a remarkable stride in artificial intelligence (AI) capabilities. This state-of-the-art video generation tool, developed using the advanced MAGVIT 2, enables users to produce high motion variable length videos with ease. Furthermore, it provides interactive editing…

Continue Reading Google’s VideoPoet: Revolutionizing AI Video Generation

“Navigating the Future: The Top 40 AI Tools Shaping Innovation Across Industries” | by Mystic Mirage | Dec, 2023

Photo by Lorenzo Herrera on Unsplash “Navigating the Future: The Top 40 AI Tools Shaping Innovation Across Industries” In the era of artificial intelligence, where innovation is driven by machine learning, deep neural networks, and automation, a myriad of AI tools is transforming the way we work, create, and solve…

Continue Reading “Navigating the Future: The Top 40 AI Tools Shaping Innovation Across Industries” | by Mystic Mirage | Dec, 2023

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / December 29, 2023 / RedChip Companies will air interviews with Genetic Technologies Limited (NASDAQ:GENE) and BioVie, Inc. (NASDAQ:BIVI) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, December 30, at 7 p.m. Eastern Time (ET). Bloomberg TV is…

Continue Reading Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV